NCT03678883 2026-04-039-ING-41 in Patients With Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT05128487 2024-11-25A Study of NDI 1150-101 in Patients With Solid TumorsNimbus TherapeuticsPhase 1/2 Active not recruiting106 enrolled